Navigation Links
Waters Showcases ACQUITY UltraPerformance LC and Mass Spectrometry (UPLC/MS) Tools for Increasing Laboratory Efficiency at the American Association for Clinical Chemistry Annual Meeting
Date:7/25/2011

ATLANTA, July 25, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today unveiled new technology solutions for increasing clinical laboratory efficiencies including the first CE Marked LC/MS/MS integrated solution for the quantification of everolimus (Certican®).

(Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO)

Being displayed in Waters booth #3136 are these exciting new products.

  • MassTrak™ Online Solid Phase Extraction Analyzer providing automated sample clean-up, concentration, and extraction complemented by Waters® ACQUITY® TQD tandem quadrupole mass spectrometer for high-sensitivity quantitative analysis.

  • MassTrak Immunosuppressants XE Kit -- CE marked in accordance with the IVD Directive 98/79/EC for the quantification of tacrolimus (FK506;Prograf®) in liver and kidney transplant patients and everolimus (Certican®)

Educational Workshops

This year, Waters is sponsoring two scientific workshops which are designed to further the education of laboratory technicians, scientists, and chemists responsible for developing, implementing, and maintaining robust clinical assays. Each workshop features presentations from leading practitioners in the field of clinical chemistry.

  • Good Method Development and Validation Practices for Liquid Chromatography -- Mass Spectrometry (LC-MS), Tuesday, July 26, 6 - 7:30 p.m., Hyatt Regency Atlanta, Regency Ballroom VII. Featured presenters: John W. Honour, Ph.D., University College London Hospitals, London, UK; Kimberly Napoli Eaton, Ph.D., Laboratory Director, Andor Laboratories, LLC, Durham, NC; and Graham Carter, DEQAS Organiser, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.  Attendees at this workshop may be eligible to receive ACCENT® educational credit hours.

  • Implementing LC/MS/MS in the Clinical Laboratory, Wednesday, July 27, 6 - 7:30 p.m., Hyatt Regency Atlanta, Centennial Ballroom III. Featured presenters: Elizabeth L. Frank, Ph.D. DABCC, Associate Professor of Pathology, University of Utah Health Science Center, Salt Lake City, UT; Shannon Harmond, Ph.D., Director - Clinical Chemistry Laboratory, Children's Memorial Hospital, Chicago, IL; Paul J. Jannetto, Ph.D., DABCC, Associate Professor of Pathology, Medical College of Wisconsin, Milwaukee, WI.

Scientific Posters

Waters scientists and customers will be presenting several scientific posters at AACC including:

  • Everolimus Measurement: Evaluating the Waters MassTrak Immunosuppressant XE Kit for use with LC/MS/MS

  • Development of a Rapid Quantitative/Semi-Quantitative LC/MS/MS Method to Monitor Opioids and Glucuronide Metabolites

  • Measurement of 25-Hydroxyvitamin D3 and C3-epi-25-Hydroxyvitamin D3 Using UPLC/MS/MS in Pediatric and Adult Populations

  • Evaluation of LC/MS/MS Scrambling Ratios for Deuterium-Labeled Vitamin D Metabolites, Steroids and Other Compounds of Clinical Significance

  • Development of an LC/MS/MS Method for 1,25 Dihydroxy Vitamin D for Use in the Clinical Laboratory

About Waters Clinical Business Operations

Working with clinical and forensic toxicology laboratories around the world, Waters has pioneered an integrated portfolio of MassTrak Solutions that include separations science, mass spectrometry, consumables, laboratory information management software, services and application support. Waters' comprehensive approach optimizes the implementation of LC/MS/MS assays in the laboratory. MassTrak Solutions bring the power of Waters technologies, including tandem mass spectrometry, in easy-to-use cost effective packages addressing therapeutic drug monitoring for everolimus and tacrolimus and for forensic toxicology. Waters innovations and laboratory solutions provide improved accuracy and precision for laboratory assays that help ensure quality results. Waters is committed to helping laboratories deliver quality results with improved levels of sample throughput, shortened turnaround times as well as increased sensitivity, specificity and flexibility.

About Waters Corporation (www.waters.com)

For over 50 years, Waters Corporation (NYSE: WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.

Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.

With revenue of $1.64 billion in 2010 and 5,400 employees, Waters is driving scientific discovery and operational excellence for customers worldwide.

Waters, MassTrak, and ACQUITY are trademarks of Waters Corporation. Prograf is a registered trademark of Astellas Pharma. Certican is a registered trademark of Novartis AG.


'/>"/>
SOURCE Waters Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Waters CE Marks In Vitro Diagnostic MassTrak Immunosuppressants XE Kit
2. Waters Introduces Ostro Sample Preparation Products
3. Waters Expands Xevo MS Instrument Platform With Next-Generation Mass Spectrometers
4. Waters Corporation and NIBRT Partner to Bring Greater Control and Predictability to Biopharmaceutical Processing
5. Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard
6. New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals
7. CIVCO Showcases RFSuite RFID Tracking and Verification System at AAPM 2011 Booth #817
8. EHE International Showcases The National Tourette Syndrome Association, Inc. with Month-Long Window Display in Rockefeller Center Plaza
9. Council on Competitiveness Showcases Power of High Performance Computing in Case Study with GNS Healthcare
10. At SIIM 2011 Siemens Showcases Imaging IT Solutions for Driving Greater Value in Radiology and Other Specialties
11. Caliper Owners Group Meeting Showcases Transformative Technologies for Advancing Personalized Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Australia,s successful biotechnology scientists, Dr Graham ... Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is seeking ... ASX. Noxopharm is a clinic-ready company with its first ... study later this year. NOX66 ... cancer patients - the ability of cancers to become resistant to ...
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg ... Legal Elite. The attorneys chosen by their peers for this recognition are considered among ... Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite Hall ...
Breaking Medicine News(10 mins):